ETBI — Eastgate Biotech Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $2.15m
- $5.23m
Annual income statement for Eastgate Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.132 | 0 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 0 | 0.113 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.606 | 1.66 | 4.82 | 4.3 | 2.82 |
| Operating Profit | -0.606 | -1.66 | -4.82 | -4.17 | -2.82 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.623 | -1.72 | -4.91 | -4.28 | -2.98 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.623 | -1.72 | -4.91 | -4.28 | -2.98 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.623 | -1.72 | -4.91 | -4.28 | -2.98 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.623 | -1.72 | -4.91 | -4.28 | -2.98 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.026 | -0.054 | -0.099 | -0.022 | -0.009 |
| Dividends per Share |